Summary
68 / 100 · Bulios Score
What speaks for it
- Revenue grew by 19% a year over the last 3 years.
- It bought back its own shares for 1.80B € in the last fiscal year, 13% of its market value.
What to watch
- Earnings per share fell by 38% a year over the last 3 years.
- It cut its dividend by 72% last year.
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 2.1 EUR for 1 EUR of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 2.6% a year over 5 years. Over the last 3 years it grew by 19% a year. Earnings per share fell by 38% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 EUR of revenue goes
- Cost of sales 18 EUR
- Sales and administration 69 EUR
- Taxes and other 3.4 EUR
- Net profit 9.9 EUR
Net profit, industry median (Insurance - Reinsurance) 9.9 EUR
Out of every 100 EUR of revenue, 9.9 EUR is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Moderate, safe- Yield
- 4.56%
- Paid out of profit
- 9.4%
You receive $0.56 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Neutral- Buy 0
- Hold 1
- Sell 0
No analyst has published a price target.
0.0% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.